These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37289567)

  • 21.
    Jin L; Yang D; Song Y; Li D; Xu W; Zhu Y; Xu CF; Lu Y; Yang X
    ACS Nano; 2022 Sep; 16(9):15226-15236. PubMed ID: 36018240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanovaccines: A game changing approach in the fight against infectious diseases.
    Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J
    Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide nanovaccine in melanoma immunotherapy.
    Dehghankhold M; Sadat Abolmaali S; Nezafat N; Mohammad Tamaddon A
    Int Immunopharmacol; 2024 Mar; 129():111543. PubMed ID: 38301413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy.
    Cai T; Liu H; Zhang S; Hu J; Zhang L
    J Nanobiotechnology; 2021 Nov; 19(1):389. PubMed ID: 34823541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic nanovaccines for immunotherapy.
    Luo M; Samandi LZ; Wang Z; Chen ZJ; Gao J
    J Control Release; 2017 Oct; 263():200-210. PubMed ID: 28336379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
    Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
    Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma.
    Chu Y; Qian L; Ke Y; Feng X; Chen X; Liu F; Yu L; Zhang L; Tao Y; Xu R; Wei J; Liu B; Liu Q
    J Nanobiotechnology; 2022 Apr; 20(1):190. PubMed ID: 35418151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancements in prophylactic and therapeutic nanovaccines.
    Bhardwaj P; Bhatia E; Sharma S; Ahamad N; Banerjee R
    Acta Biomater; 2020 May; 108():1-21. PubMed ID: 32268235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unprecedented Chiral Nanovaccines for Significantly Enhanced Cancer Immunotherapy.
    Liu H; Xie Z; Zheng M
    ACS Appl Mater Interfaces; 2022 Sep; 14(35):39858-39865. PubMed ID: 36007113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The quest for nanoparticle-powered vaccines in cancer immunotherapy.
    Sun Z; Zhao H; Ma L; Shi Y; Ji M; Sun X; Ma D; Zhou W; Huang T; Zhang D
    J Nanobiotechnology; 2024 Feb; 22(1):61. PubMed ID: 38355548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting.
    Achmad H; Saleh Ibrahim Y; Mohammed Al-Taee M; Gabr GA; Waheed Riaz M; Hamoud Alshahrani S; Alexis Ramírez-Coronel A; Turki Jalil A; Setia Budi H; Sawitri W; Elena Stanislavovna M; Gupta J
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109434. PubMed ID: 36402068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination of TLR7/8 Agonist-Conjugated Antigen Nanoparticles for Cancer Immunotherapy.
    Wang N; Zhang G; Zhang P; Zhao K; Tian Y; Cui J
    Adv Healthc Mater; 2023 Sep; 12(22):e2300249. PubMed ID: 37016572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Antigen-Based Nanovaccines for Cancer Immunotherapy: A Review.
    Zhao J; Du G; Sun X
    J Biomed Nanotechnol; 2021 Nov; 17(11):2099-2113. PubMed ID: 34906272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
    Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
    Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal stratified imaging of nanovaccines in lymph nodes for improving cancer immunotherapy.
    Tian R; Ke C; Rao L; Lau J; Chen X
    Adv Drug Deliv Rev; 2020; 161-162():145-160. PubMed ID: 32827558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy.
    Zhu G; Mei L; Vishwasrao HD; Jacobson O; Wang Z; Liu Y; Yung BC; Fu X; Jin A; Niu G; Wang Q; Zhang F; Shroff H; Chen X
    Nat Commun; 2017 Nov; 8(1):1482. PubMed ID: 29133898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbon Dots and Tumor Antigen Conjugates as Nanovaccines for Elevated Cancer Immunotherapy.
    Liu H; Xie Z; Zheng M
    Small; 2023 Aug; 19(31):e2206683. PubMed ID: 36978241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cell-based nanovaccines for cancer immunotherapy.
    Paulis LE; Mandal S; Kreutz M; Figdor CG
    Curr Opin Immunol; 2013 Jun; 25(3):389-95. PubMed ID: 23571027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-Adjuvanting Polyguanidine Nanovaccines for Cancer Immunotherapy.
    Zhang X; Wang K; Zhao Z; Shan X; Wang Y; Feng Z; Li B; Luo C; Chen X; Sun J
    ACS Nano; 2024 Mar; 18(9):7136-7147. PubMed ID: 38407021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.